🔎 Trials Near Me

Akèy › Gliyòm › New York

Etid klinik pou Gliyòm nan New York

28 etid pou Gliyòm ap chèche patisipan nan sit nan New York.

Vil nan New York

Tèks ofisyèl etid la (Anglè)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

  • Albany Medical Center, Albany
  • Roswell Park Cancer Institute, Buffalo
  • The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
  • ak 4 plis
Ap rekriteFaz 1/2
12 Months – 21 Years · Tout sèks · Mizajou Oct 1, 2026 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Northwell Health Center for Advanced Medicine - Brain Tumor Center, Lake Success
  • Columbia University Irving Medical Center, New York
  • Montefiore Medical Center, The Bronx
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07326566

A Study of Mirdametinib in People With Central Nervous System Tumors

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • ak 1 plis
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07539441

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

  • Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
  • Memorial Sloan Kettering West Harrison (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • ak 1 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT05489783

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • NYU Langone Health, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University Medical Center, New York
  • ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT05303519

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

  • New York University, New York
Ap rekriteFaz 1
Laj 1 a 25 · Tout sèks · Mizajou Aug 18, 2026 · NCT04485559

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

  • Research Site, New York
  • Research Site, New York
Ap rekriteFaz 1/2
Laj 18 a 130 · Tout sèks · Mizajou Aug 12, 2026 · NCT05417594

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

  • New York Presbyterian Hospital-Columbia University Medical Center, New York
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT07486713

A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

  • NYU Langone Health, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07464925

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 2
Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

  • Memorial Sloan Kettering Suffolk -Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • ak 1 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT05188508

Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma

  • NYU Langone Health, New York
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Jul 21, 2026 · NCT06910306

MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas

  • Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1/2
Laj 1 a 26 · Tout sèks · Mizajou Jul 10, 2026 · NCT06712875

Chronic CED of TPT for Recurrent Malignant Glioma

  • Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT06666712

A Study of 177Lu-PSMA-617 in People With Gliomas

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • ak 1 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT07223034

Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma

  • Lenox Hill Brain Tumor Center, New York
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT05954858

Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

  • Lenox Hill Brain Tumor Center, New York
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT05271240

Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)

  • Lenox Hill Brain Tumor Center, New York
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT05979064

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

  • Roswell Park, Buffalo
  • Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
  • Columbia University Medical Center, New York
  • ak 1 plis
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Apr 20, 2026 · NCT06326411

Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252

  • Memorial Sloan Kettering, New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Apr 15, 2026 · NCT06126744

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

  • NYU Langone Health, New York
  • Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT06810544

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

  • Lenox Hill Brain Tumor Center, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT02800486

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

  • Northwell Health, Lake Success
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Mar 11, 2026 · NCT06504381

FUS Etoposide for DMG

  • Columbia University Irving Medical Center, New York
Ap rekriteFaz 1
Laj 4 a 21 · Tout sèks · Mizajou Jan 28, 2026 · NCT05762419

Concurrent XRD-0394 With Radiation Therapy for High Grade Gliomas

  • NYU Langone Health, New York
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Jan 2, 2026 · NCT06829173

Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma

  • University of Rochester, Rochester
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT04543201

Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)

  • Northshore University Hospital, Manhasset
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Mar 26, 2025 · NCT01906385

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.